Sunday, October 8, 2017

IDWeek 2017 Coverage - Brianna Norton, DO: Hepatitis C Treatment

Brianna Norton, DO: Hepatitis C Treatment
OCTOBER 07, 2017
Jenna Payesko
I think that really the majority the core of the Hep C epidemic is among people who use drugs. For a long time, the largest population was baby boomers and now because of the expanding opioid epidemic in the US there's actually a lot of younger people who are acquiring Hep C...

Conference News 
MD Magazine 
Oct 4 - 8

NATAP Conference Coverage - ID Week
ID Week San Diego CA
October 4-8, 2017
Barriers to Hepatitis C Treatment in HIV co-infected Patients in the Era of New Direct-Acting Antiviral Therapy (Philadelphia): Just Over Half With HCV/HIV at Academic Center Get DAAs for HCV
Just over 50% of HCV/HIV-coinfected people in care at a Philadelphia academic center got treated for HCV with direct-acting antivirals (DAAs) in 2016 [1]. A detectable HIV load and substance abuse emerged as apparent barriers to DAA therapy.
View coverage -

No comments:

Post a Comment